Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03604172 · ClinicalTrials.gov registry record · NA

Neural Response to Food Stimuli: fMRI Changes Following Cognitive Behavioral Therapy for Binge Eating Disorder

A NA study of Overweight and Obesity and Binge-Eating Disorder, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03604172 is a NA study of Overweight and Obesity and Binge-Eating Disorder that has completed, run by University of Pennsylvania. The registered enrollment target is 40 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03604172, a NA study of Overweight and Obesity and Binge-Eating Disorder, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to conduct a randomized controlled trial (RCT) assessing the impact of CBT on neural responses to binge eating stimuli.

Interventions

  • BEHAVIORAL Waitlist
  • BEHAVIORAL Cognitive behavioral therapy

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-08-08
Est. Completion 2021-11-22
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT03604172

The ClinicalTrials.gov registry entry for NCT03604172 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (82% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Overweight and Obesity appearing as the primary indexed condition, and to 2 interventions - of which Waitlist is the first listed.

NCT03604172 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03604172 about?

NCT03604172 is a clinical study titled "Neural Response to Food Stimuli: fMRI Changes Following Cognitive Behavioral Therapy for Binge Eating Disorder". The purpose of this research is to conduct a randomized controlled trial (RCT) assessing the impact of CBT on neural responses to binge eating stimuli.

What is the current status of trial NCT03604172?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-08-08. Estimated completion is 2021-11-22.

What conditions does trial NCT03604172 study?

This clinical trial studies the following conditions: Overweight and Obesity, Binge-Eating Disorder.

What interventions are being tested in trial NCT03604172?

The interventions under investigation include: Waitlist (BEHAVIORAL), Cognitive behavioral therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT03604172?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03604172 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.